Douglas Hudson left the role of Director at Allurion Technologies, Inc. As of November 6, 2026, Allurion Technologies, Inc. has reported 4 leadership change filings to the SEC under Item 5.02 of Form 8-K, from June 30, 2026 to August 24, 2026, naming 2 departures (Form 8-K, July 7, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Allurion Technologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-08-24
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-07-23
- · In / out: Out · Person: Douglas Hudson · Role: Director · 8-K, 2026-07-07
- · In / out: Out · Person: R. Jason Richey · Role: Director · 8-K, 2026-06-30
Allurion Technologies, Inc. reported changes in 4 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-06-30 to 2026-08-24. They name 2 people. Every row below is cited to the filing it comes from, and this page adds each new change as Allurion Technologies, Inc. files it.
Also on the record for Allurion Technologies, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 2, 2026 | Stake report, Schedule 13D/A, by RTW Investments, LP | 9.9% of the class | 5%+ stakes | Source |
| July 23, 2026 | Stake report, Schedule 13D/A, by RTW Investments, LP | 9.9% of the class | 5%+ stakes | Source |
| March 2, 2026 | Stake report, Schedule 13D/A, by RTW Investments, LP | 39.4% of the class | 5%+ stakes | Source |
| November 26, 2025 | Form D, private offering | $5M sold | Form D page | Source |
| November 13, 2025 | Stake report, Schedule 13D/A, by RTW Investments, LP | 48.1% of the class | 5%+ stakes | Source |
| November 7, 2025 | Stake report, Schedule 13D/A, by RTW Investments, LP | 43.6% of the class | 5%+ stakes | Source |
| February 7, 2025 | Form D, private offering | $7.44M sold | Form D page | Source |
Selling to them or working with them? See who runs Allurion Technologies, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Allurion Technologies, Inc. and the records around it.
Allurion Technologies, Inc. elsewhere on the record
- Form D filing Nov 2025
- Who owns it
Companies that share a holder
- RTW Investments, LP also filed stake reports on 43 other companies: CG Oncology, Inc. (Aug 2026), iRhythm Holdings, Inc. (Aug 2026), Kailera Therapeutics, Inc. (Aug 2026)
Watch Allurion Technologies, Inc.
Get an email when Allurion Technologies, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Allurion Technologies, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Allurion Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Allurion Technologies, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-24 | Reported | not named in the filing | 8-K, 2026-08-24 | ||
| 2026-07-23 | Reported | not named in the filing | 8-K, 2026-07-23 | ||
| 2026-07-07 | Out | Director | 8-K, 2026-07-07 | ||
| 2026-06-30 | Out | Director | 8-K, 2026-06-30 |
Who leads Allurion Technologies, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Douglas Hudson, departure reported (filed 2026-07-07). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Allurion Technologies, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Allurion Technologies, Inc., with the record behind each one.
Find candidates like Director at Allurion Technologies, Inc.Every change, in the filing's words
Reported
On August 17, 2026, Krishna Gupta, a Class I member of the board of directors (the "Board") of Allurion Technologies, Inc. (the "Company"), notified the Company of his resignation from the Board and position on the Nominating and Corporate Governance Committee of the Board, effective the same day.
- On August 19, 2026, Michael Davin, a Class III member of the Board of the Company, notified the Company of his resignation from the Board and as Chairman of the Compensation Committee and position on the Audit Committee of the Board, effective the same day.
- In connection with these resignations, the Board voted to reduce the size of the Board from five members to three members.
Reported
On July 17, 2026, Shantanu K. Gaur, M.D. notified Allurion Technologies, Inc. (the " Company ") of his resignation as Chief Executive Officer of the Company and as a member of the Company's board of directors (the " Board "), in each case effective immediately.
- Dr. Gaur's resignation was not the result of any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices.
- In connection with Dr. Gaur's resignation, the Board has not appointed an interim or permanent Chief Executive Officer.
- Ojas Buch, the Company's Chief Operating Officer, will oversee the Company's day-to-day operations, including certain responsibilities previously performed by Dr. Gaur.
- Mr. Buch's title and compensation arrangements have not been modified in connection with these responsibilities.
Departing: Douglas Hudson, Director
On June 30, 2026, Douglas Hudson, a Class II member of the board of directors (the "Board") of Allurion Technologies, Inc. (the "Company"), notified the Company of his resignation from the Board and position on the Nominating and Corporate Governance Committee of the Board, effective the same day.
- Mr. Hudson's resignation was not the result of any disagreement with management or the Board or on any matter relating to the Company's operations, policies or practices.
- The Board is currently evaluating which of its directors will replace Mr. Hudson on the Nominating and Corporate Goverance Committee.
Departing: R. Jason Richey, Director
On June 24, 2026, R. Jason Richey, a Class II member of the board of directors (the "Board") of Allurion Technologies, Inc. (the "Company"), notified the Company of his resignation from the Board and his role as the chairperson of the Audit Committee of the Board (the "Audit Committee"), effective the same day.
- Mr. Richey's resignation was not the result of any disagreement with management or the Board or on any matter relating to the Company's operations, policies or practices.
- The Board is currently evaluating which of its directors will replace Mr.Richey as chairperson of the Audit Committee.
Tools for this story
Each opens in a new tab, filled in for Allurion Technologies, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.